Dementia , Looking Back to Move Forward
Dr. Whitmer’s presentation will focus on modifiable risk factors over the lifecourse and how health in early life impacts cognitive aging. She will discuss risk factors to reduce dementia over one’s lifetime and how living a healthy lifestyle early on can positively impact cognitive aging. Dr. Whitmer will also address the concept of brain health as a lifetime pursuit, the importance of conducting studies in diverse populations, and the launch of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) trial. U.S POINTER is the first multi-domain behavioral intervention trial to reduce cognitive impairment funded by the Alzheimer’s Association.
Wednesday October 16th, 2019
6:30pm – Reception with light refreshments
7pm – Program
The Dorothy and Charles Mosesian Center for the Arts
321 Arsenal St.
Watertown, MA 02472
Free to attend. Free garage parking onsite.
Visit here for driving, public transit, and parking directions.
Rachel Whitmer, PhD
Professor, Public Health Sciences
Chief, Division of Epidemiology
Associate Director, Alzheimer’s Disease Research Center
UC Davis School of Medicine
Since 1991, the annual Matthew & Marcia Simons Research Symposium on Alzheimer’s disease has been the centerpiece of the Alzheimer’s Association, MA/NH Chapter’s yearly scientific presentations, highlighting the work of scientists making major contributions to the search for causes, treatments and ultimate cure for Alzheimer’s disease.
The Alzheimer’s Association honors the spirit and dedication of longtime Board of Directors member Marcia Simons, whose commitment to support and education for those coping with Alzheimer’s disease led her in 1991 to endow The Matthew & Marcia Simons Research Symposium on Alzheimer’s Disease. Twenty-eight years later, the Alzheimer’s Association continues to honor Marcia Simons and her family by highlighting the work of scientists making major contributions to the search for causes, treatments and ultimate cure for Alzheimer’s disease.